Is longevity medicine is worth outcomes or just a hoax. What are the medical specialties which ll bloom in coming 15-20years-in what way?like currently nuclear medicine?
longevity medicine evidence clinical outcomes 2025 2026
medical specialties future growth 2030 2040 emerging fields
longevity medicine senolytics aging hallmarks clinical trial
emerging medical specialties artificial intelligence precision medicine future
PMID: 41957871
hallmarks of aging therapeutic targets senescence rapamycin metformin
regenerative medicine stem cell therapy clinical outcomes future
| Compound / Approach | Mechanism | Evidence Status |
|---|---|---|
| Metformin (TAME trial) | AMPK activation, mTOR inhibition, SASP suppression | FDA accepted first aging-as-outcome trial; primate data shows -6.41 years biological age |
| Rapamycin / mTOR inhibitors | mTORC1 inhibition, extends lifespan in multiple species | Strong animal data; human RCTs ongoing |
| Senolytics (Dasatinib + Quercetin) | Clears senescent cells | Phase 2 trials in IPF, CKD, Alzheimer's |
| SGLT-2 inhibitors | Indirect senolytic via immunosurveillance enhancement | Already in clinical use; aging benefits emerging |
| GLP-1 receptor agonists | Attenuate inflammaging, metabolic recalibration | Strong real-world data; aging applications expanding |
| NAD+ precursors (NMN, NR) | Mitochondrial restoration, sirtuin activation | Biomarker data positive; hard outcome trials pending |
| Multidomain lifestyle programs | Multiple hallmarks simultaneously | RCTs show measurable intrinsic capacity improvement (WHO ICOPE framework) |
| Specialty | Current Status | Bloom Drivers | Timeline |
|---|---|---|---|
| Geromedicine | Nascent | Demographics, TAME trial, ICD-11 aging codes | 2030-2035 |
| Computational/AI Medicine | Informatics fringe | AI regulation, diagnostic AI ubiquity | 2028-2032 |
| Cellular Therapy Medicine | Within oncology | CAR-T expansion to 50+ indications | 2030-2040 |
| Neurodegeneration Medicine | Within neurology | Anti-amyloid drugs, biomarkers | 2030-2038 |
| Cardiometabolic Medicine | Siloed | GLP-1 breadth, metabolic pandemic | 2028-2035 |
| Genomic/Epigenomic Medicine | Clinical genetics | WGS cost drop, CRISPR therapies | 2032-2040 |
| Theranostics (expanded NucMed) | Subspecialty | Radioligand pipeline, targeted alpha therapy | 2026-2033 |
| Preventive Cardiology | Subspecialty | LP(a) therapies, polygenic risk | 2028-2034 |
Cardio+geroatric -I feel the best combo,how would it shape to make niche. see I am anesthesiologist,however I don’t just to practice this for long. I want cardio+geriatric(may be not intervention)but obviously something which must take-Geriatric with cardiac care.Dont give overhyped and unrealistic answers,you can do this-that. How I can make this my niche?I work in cadiac centre hence interested understanding the dynamics.
geriatric cardiology frailty cardiac outcomes older adults
frailty assessment cardiac surgery TAVR outcomes anesthesia
geriatric cardiology subspecialty training pathway 2024 2025 career
PMID: 39056350
PMID: 37289174
frailty TAVR transcatheter valve elderly perioperative outcomes
cardiac rehabilitation older adults frailty geriatric assessment heart failure
PMID: 39327412
PMID: 40608851
comprehensive geriatric assessment cardiology heart failure multimorbidity older patients
PMID: 41598685
"Conventional cardiology models, largely derived from younger and selected populations, often fail to adequately address the complexity of cardiovascular care in older adults. Despite the growing development of cardiogeriatrics, the core competencies required for contemporary geriatric cardiology practice remain insufficiently defined."
You are thinking of me as an Anesthesiologist aiming to practice Anesthesia part of geriatric cardiology. No I wanna the physician for all geriatric +cardiology issues in then(non-interventional).Are you getting ot?
geriatric cardiology non-interventional clinical practice HFpEF multimorbidity frailty management
anesthesiologist career transition internal medicine physician retraining pathway
anesthesiologist transition to cardiology geriatrics physician career change MD retraining pathway
| Phase | Action | Duration |
|---|---|---|
| Now | FCC (Cardiological Society of India) enrollment + Geriatric Medicine diploma | 12-18 months alongside practice |
| Year 1-2 | Shift clinical role in current centre toward heart failure/geriatric cardiac patients | Ongoing |
| Year 2-3 | Either: enter DM Cardiology (cleanest path) OR establish a clinic with combined credentials | Decision point |
| Year 4-5 | Independent non-interventional geriatric cardiology practice | Goal state |
Then pivot me in a role where I work on consultation basis for all geriatric issues with multiple comorbs posted for surgery. The second opinion stuff. No long term-long path bullshit.
perioperative medicine consultation elderly frailty preoperative optimization surgical outcomes
perioperative geriatric consultation multimorbidity cardiac surgery risk stratification CGA
perioperative medicine specialty physician role preoperative assessment
preoperative geriatric assessment frailty cardiac risk elderly surgery outcomes
| Layer | What it requires | Your existing competence |
|---|---|---|
| Cardiac risk | Coronary physiology, LV function, valvular disease impact on surgery | Strong - you manage this intraoperatively daily |
| Perioperative pathophysiology | What happens to a frail 80-year-old's physiology under surgical stress | Strong - this is your core training |
| Multi-comorbidity pharmacology | Anticoagulants, antiplatelets, antihypertensives, diabetic drugs peri-op | Strong - you manage all of these before every case |
| Month | Action |
|---|---|
| 1-3 | Learn CGA tools, apply them to your existing patients, no formal credential needed yet |
| 3-6 | Propose and start a pre-surgical geriatric assessment service within your centre (even informally) |
| 4-8 | Enroll in Faculty of Perioperative Care fellowship or equivalent online program |
| 6-12 | Have 50+ patients assessed, outcomes tracked, first audit/paper drafted |
| 12 | You have a credential, a dataset, a running service, and a clear identity |
Extensively search yourself and tell all the possible tools/scores to assess all that including clinically/symptomatic/labs/imaging in the type of patient I am looking for,geriatrics with all possible comorbities,how can I position. Injust dont want to practice in a hospital,I an online presence for online consultations.
comprehensive geriatric assessment tools frailty cognitive function preoperative elderly
preoperative cardiac risk scores elderly multimorbidity surgery stratification
telemedicine online consultation preoperative assessment elderly surgical patient
PMID: 39410557
PMID: 39916728
polypharmacy STOPP START criteria elderly surgery preoperative deprescribing
digital health telemedicine physician online practice model second opinion geriatric
20 seconds = severely impaired; >12 seconds = moderate impairment
| Lab | Why | Threshold to flag |
|---|---|---|
| CBC | Anemia (30-day mortality predictor), baseline lymphopenia | Hb <10 g/dL; Plt <100 |
| Renal function (Cr, eGFR, BUN) | CKD stages surgical risk; contrast for imaging; drug dosing | eGFR <30 = major risk |
| Electrolytes (Na, K, Mg) | Arrhythmia risk; diuretic effects in elderly | Na <130, K <3.2 or >5.5 |
| Liver function | Albumin, coagulation substrate, drug metabolism | Albumin <3.0 |
| Fasting glucose + HbA1c | DM control; HbA1c >8.5 = suboptimal; delay elective surgery | HbA1c >9 = flag |
| NT-proBNP / BNP | Cardiac stress marker; perioperative MACE predictor | NT-proBNP >300 ng/L |
| Troponin (high-sensitivity) | Baseline; any elevation = occult cardiac disease | Any elevation above normal |
| Thyroid (TSH) | Hypo/hyperthyroidism affect cardiac physiology and drug metabolism | Out of range |
| Coagulation (PT, INR, aPTT) | Anticoagulant patients; liver disease | INR >1.5 unintentional |
| Lipid profile | Statin optimization before surgery | LDL >100 in high-risk |
| 25-OH Vitamin D | Deficiency = muscle weakness, frailty, poor healing | <20 ng/mL |
| Serum albumin + prealbumin | Nutritional status | Albumin <3.5 |
| Urine routine + culture | UTI is common delirium precipitant in elderly; silent in many | Any infection |
| Test | What you look for |
|---|---|
| ECG | LVH, prior MI (Q waves), arrhythmias (AF - common in elderly), conduction disease, prolonged QTc (drug interactions) |
| Echocardiography (TTE) | LV systolic function (EF), diastolic dysfunction grade (especially HFpEF), valvular disease severity (AS, MR, AR), RVSP (pulmonary hypertension), wall motion abnormalities |
| Chest X-ray | Cardiomegaly, pulmonary congestion, pleural effusion, aortic calcification, COPD changes |
| Stress Echo / Nuclear stress test | Inducible ischemia - request if RCRI ≥2 + poor functional capacity + high-risk surgery |
| Coronary CT Angiography (CCTA) | Calcium scoring + anatomy in intermediate-risk elderly patients; useful when stress test inconclusive |
| Test | Purpose |
|---|---|
| Spirometry (PFTs) | FEV1/FVC, FEV1% predicted; FEV1 <50% = high pulmonary risk |
| Room air SpO2 | <94% = flag; baseline hypoxemia doubles pulmonary complications |
| ABG | If COPD or suspected CO2 retention |
| 6-minute walk test | Distance <300m = poor pulmonary/cardiac reserve |
It’s important to see each domain,but its wrong to see via different lens. I hope you get it.6 fraility scores will only complicate the issue. And similarly others. We need one perfect tool for each domain,isn’t it. Also its India I cannot overcharge.Seeing ll tell me is Surgery safe to tell patients/relatives, which form of anesthesia is best. Pre-optimization timeline,where surgeons don’t give a day,the whole Anesthesia protocol fails,so more of domain tools/protocols-practically feasible.
single frailty tool prediction surgical outcomes elderly validation comparison
ERAS enhanced recovery elderly frailty anesthesia protocol perioperative
Clinical Frailty Scale CFS surgical outcomes prediction validation elderly
regional anesthesia versus general anesthesia elderly frailty cognitive outcomes
PMID: 37567604
preoperative optimization short timeline rapid anemia correction elderly surgery
FRAILTY (reserve tank size)
+ CARDIAC RISK (how hard the pump is working)
+ COGNITION (brain vulnerability)
+ NUTRITION (fuel quality)
+ COMORBIDITY BURDEN (number of systems already stressed)
+ FUNCTIONAL STATUS (real-world output of all of the above)
↓
ONE RISK CLASSIFICATION
↓
Safe? / Which anesthesia? / Optimize how, in how long?
6 = Very high → <10% 10-year survival
| Drug class | Why it matters perioperatively | Action |
|---|---|---|
| NSAIDs | Renal failure, GI bleed, fluid retention worsens HF | STOP 1 week pre-op |
| Long-acting sulfonylureas (glibenclamide) | Hypoglycemia risk perioperatively | Switch to short-acting or insulin protocol |
| ACEi/ARB | Intraoperative hypotension, AKI | Hold morning of surgery (but restart within 48h post-op) |
| Anticoagulants (warfarin, DOACs) | Bleeding vs thrombosis bridge decision | Bridge if high thrombotic risk; hold if low |
| Antiplatelets (clopidogrel) | Timing depends on surgery type and stent history | DES within 12 months = do NOT stop without cardiology input |
| Benzodiazepines | Delirium, respiratory depression, prolonged sedation in elderly | Taper pre-op if on chronically; avoid new prescriptions |
| Anticholinergics | Postoperative delirium, urinary retention | Stop: tricyclics, older antihistamines, bladder drugs, certain antispasmodics |
| Digoxin >125 mcg/day in eGFR <30 | Toxicity risk | Review dose/level |
| CFS | RCRI | MoCA | Albumin | Risk Classification |
|---|---|---|---|---|
| 1-4 | 0-1 | ≥26 | >3.5 | GREEN - Proceed |
| 5-6 | 1-2 | 18-25 | 3.0-3.5 | YELLOW - Optimize then proceed |
| 7-8 | ≥2 | <18 | <3.0 | ORANGE - High risk; discuss goals; can proceed if surgery is necessary |
| Any | ≥3 | Any | <2.5 | RED - Prohibitive for elective; goals-of-care conversation first |
"Your father has the reserve of someone who is significantly weaker than his age on paper suggests. If we operate today, there is approximately a 1-in-5 chance he does not recover to where he is now - either he stays in hospital longer, goes to a nursing facility, or in the worst case does not survive the next 3 months. That is not a reason to not operate if the disease will kill him faster. But it is a reason to be clear-eyed about what we are doing."
| Patient Profile | Anesthesia Recommendation |
|---|---|
| CFS 1-4, MoCA ≥26, good cardiac reserve | General anesthesia with standard ERAS protocol - no restriction |
| CFS 5-6, MoCA 20-26, RCRI 1-2 | Prefer regional/neuraxial if surgically feasible. Reduces POCD, delirium, respiratory complications. If GA needed: TIVA preferred over volatile agents (emerging evidence for lower POCD). Minimize benzodiazepine premedication. BIS monitoring recommended. |
| CFS 5-6, MoCA 18-22, RCRI ≥2 | Regional/neuraxial strongly preferred. If GA unavoidable: TIVA, BIS-guided, dexmedetomidine infusion for sedation (lower delirium than propofol bolus), avoid anticholinergics (atropine/glycopyrrolate), sugammadex over neostigmine for reversal |
| CFS ≥7, MoCA <18, RCRI ≥2 | Neuraxial only if feasible. If GA absolutely required: shortest possible duration, lightest depth compatible with analgesia, ICU post-op mandatory, immediate family briefing on delirium likelihood |
| Any patient with severe AS/MR, EF <35% | Haemodynamic-stable induction essential regardless of technique; arterial line mandatory; avoid spinal hypotension |
No discussion on AKI/ CKD/sugars/HTN/autoimmune pathology/respiratory conditions/type of surgery-very impressive discriminator?
perioperative AKI CKD elderly surgery prevention management outcomes
perioperative diabetes hyperglycemia management elderly surgery outcomes
perioperative hypertension management elderly surgery risk cardiovascular
PMID: 41111125
perioperative respiratory COPD OSA pulmonary risk noncardiac surgery elderly
surgical risk stratification type surgery high intermediate low cardiac complications
| Risk Category | 30-day MACE risk | Surgery Types |
|---|---|---|
| LOW (<1%) | Superficial, endoscopic, breast, cataract, minor orthopedic (knee arthroscopy), minor urology | Proceed without cardiac evaluation if no active cardiac condition |
| INTERMEDIATE (1-5%) | Intraperitoneal (cholecystectomy, colectomy, hernia repair), intrathoracic, orthopedic (hip/knee replacement), prostate, head/neck, renal transplant | Full assessment required; frailty + RCRI + echo if indicated |
| HIGH (>5%) | Aortic/major vascular, peripheral vascular, major thoracic (pneumonectomy), pancreatic/esophageal surgery, emergency surgery (any type) | Full CGA mandatory; high threshold to proceed in frail elderly |
| eGFR | Stage | Perioperative implication |
|---|---|---|
| >60 | 1-2 | Standard precautions |
| 30-59 | 3 | Avoid nephrotoxins; hold ACEi/ARB day of surgery; avoid contrast if possible; check K |
| 15-29 | 4 | High AKI risk; avoid ACEi, NSAIDs, gentamicin; flag anesthesiologist for fluid strategy; nephrology consult before elective surgery |
| <15 / dialysis | 5 | Surgery on dialysis-free day preferred; coordinate with nephrology; K must be <5.5 on day of surgery |
| HbA1c | Interpretation | Action |
|---|---|---|
| <7.5% | Well controlled | Proceed; adjust medication for fasting |
| 7.5-9% | Acceptable for surgery | Medication adjustment; peri-op glucose target 140-180 mg/dL |
| 9-10% | Suboptimal | Optimize if 2+ weeks available; if urgent, proceed with tight glucose monitoring |
| >10% | Poor control | Delay elective surgery; intensify management; risk of wound infection x3, AKI x2 |
| Condition | Key parameter | Threshold that changes management |
|---|---|---|
| COPD | FEV1% predicted | <50% = high PPC risk; <30% = very high risk |
| OSA | STOP-BANG score + confirmed diagnosis | Score ≥3 or confirmed moderate-severe OSA = flag anesthesiologist for airway management + post-op monitoring |
| Interstitial Lung Disease (ILD/IPF) | DLCO% + baseline SpO2 | DLCO <50% or SpO2 <94% at rest = very high PPC risk |
| Active smoking | Pack-year history | Even 4 weeks cessation reduces PPC risk significantly |
| Drug | Perioperative action |
|---|---|
| Low-dose prednisolone (≤10 mg/day) | Continue; give stress dose hydrocortisone if major surgery (50-100mg IV at induction, taper over 24-48h) |
| High-dose steroids (>10 mg/day) | Mandatory stress dosing; higher adrenal suppression risk |
| Methotrexate | Continue perioperatively (evidence shows stopping increases flare risk without reducing infection) |
| Biologics (TNF inhibitors, rituximab, tocilizumab) | Withhold for 1 drug half-life before elective surgery (adalimumab 2 weeks; rituximab 6 months); restart when wound healed (2-4 weeks) |
| Hydroxychloroquine | Continue - no perioperative risk; stopping causes flare |
| Leflunomide | Continue for minor surgery; discuss with rheumatologist for major surgery |
LOW SURGERY RISK INTERMEDIATE HIGH SURGERY RISK
(cataract, hernia) (bowel, joint (vascular, thoracic,
replacement) emergency)
CFS 1-4 + ✅ Proceed ✅ Proceed ⚠️ Optimize + proceed
No major comorbidity Standard care Standard ERAS Full CGA + optimization
CFS 5-6 + ✅ Proceed ⚠️ Optimize 🔴 High-risk counsel
Moderate comorbidity POCD prevention Full CGA Goals of care discussion
+ drug sweep + optimization Consider less invasive Rx
CFS ≥7 OR ⚠️ Weigh need 🔴 High-risk 🔴🔴 Prohibitive
Severe comorbidity carefully counsel unless life-saving
(EF<30, eGFR<20, Goals of care Family/patient Goals-of-care first
Albumin <2.5) discussion discussion Palliative option?
"Based on CFS 7, eGFR 22, albumin 2.8, and the surgical risk category of this procedure, the 30-day mortality estimate is 25-35%. This is not a contraindication if the condition being treated has worse natural history - but the family must understand these are the numbers before consenting. I recommend a goals-of-care family meeting before proceeding."
See I can’t publish all this anywhere. The task is for me to understand whole issue comprehensively from CFS/geriatric/in all last to last response and this response to position me for geriatric population surgery of any kind- an Anesthesiologist-the sole manager of all this with CONSULTATION OF SAME.
SURGICAL STRESS DEMAND PATIENT RESERVE TIME AVAILABLE
(how hard will surgery hit?) × (how much can they absorb?) ÷ (how much can we change?)
↓ ↓ ↓
Surgery Risk Class CGA Score Tier 1/2/3 Protocol
↓ ↓ ↓
ONE CONSULTATION REPORT
↓
Safe? → Which Anaesthesia? → Optimize How?
| Class | MACE Risk | Examples |
|---|---|---|
| LOW | <1% | Cataract, endoscopy, superficial skin, breast, minor dental, TURP (small), knee arthroscopy |
| INTERMEDIATE | 1-5% | Laparoscopic cholecystectomy/colectomy, hip/knee replacement, TURP (large), hernia (mesh), renal surgery, prostate open, head-neck |
| HIGH | >5% | Open AAA/vascular, major thoracic (pneumonectomy/esophagectomy), major hepatobiliary (Whipple), emergency surgery of any kind |
| CFS | Description | Surgical Implication |
|---|---|---|
| 1-2 | Fit/Well - exercises regularly | No frailty-related risk |
| 3 | Managing well - active but not exercising | Minimal frailty risk |
| 4 | Vulnerable - slow, symptoms limit activity but not daily help | Pre-frail: proceed with ERAS |
| 5 | Mildly frail - needs help with IADLs (finances, transport) | Optimization mandatory; anesthesia preference regional |
| 6 | Moderately frail - needs help with ADLs (bathing, dressing) | High-risk conversation required; aggressive optimization |
| 7 | Severely frail - completely dependent for all personal care | Red zone: goals-of-care discussion before surgical consent |
| 8 | Very severely frail - approaching end of life | Surgery serves only palliation; make this explicit |
| 9 | Terminally ill | No surgical optimization meaningful |
| Score | Interpretation | Action |
|---|---|---|
| 26-30 | Normal | Baseline documented; standard POCD prevention |
| 22-25 | Mild cognitive impairment | Delirium high risk; document baseline; brief family on delirium |
| 18-21 | Moderate MCI | Regional preferred; minimize sedation; HDU post-op recommended |
| 10-17 | Moderate-severe impairment | GA carries significant POCD risk; goals discussion with family; ICU post-op |
| <10 | Severe | Surgery rationale must be carefully examined |
| Lab | Value | Risk | Action |
|---|---|---|---|
| Albumin | >3.5 | Normal | None |
| Albumin | 3.0-3.5 | Mild malnutrition | ONS (oral nutritional supplements) 2 weeks pre-op |
| Albumin | <3.0 | Severe malnutrition | Delay elective surgery; if urgent - wound healing/infection risk counselled |
| Albumin | <2.5 | Prohibitive malnutrition | Elective surgery contraindicated until corrected |
| Hb | >10 | Normal | None |
| Hb | 8-10 | Mild-moderate anaemia | IV iron if 3+ weeks; oral iron if >6 weeks; flag anaesthesiologist |
| Hb | <8 | Severe anaemia | Must correct before elective surgery; transfuse if emergency |
| Drug | Stop/Modify | When | Why |
|---|---|---|---|
| NSAIDs (ibuprofen, diclofenac, naproxen) | STOP | 5-7 days pre-op | AKI, GI bleed, platelet dysfunction |
| Metformin | STOP | 24-48h pre-op | Lactic acidosis if AKI; also if contrast used |
| SGLT-2 inhibitors | STOP | 3-4 days pre-op | Euglycaemic DKA risk perioperatively |
| Long-acting sulfonylureas (glibenclamide) | STOP | 48h pre-op | Hypoglycemia with fasting |
| ACEi/ARB | HOLD | Morning of surgery | Intraoperative hypotension → AKI |
| Anticoagulants (warfarin/DOACs) | ASSESS | Case-by-case | Bridge if AF + high stroke risk; hold if low risk |
| Antiplatelet (clopidogrel) | DO NOT STOP | If DES <12 months | Stent thrombosis > surgical bleeding risk |
| Benzodiazepines (chronic use) | TAPER | 2 weeks if possible | Delirium, respiratory depression, prolonged sedation |
| Anticholinergics (TCAs, oxybutynin, old antihistamines) | STOP | 1 week pre-op | Delirium, urinary retention |
| GLP-1 agonists (semaglutide injection) | HOLD | Day of surgery | Gastroparesis → aspiration risk |
| Beta-blockers | CONTINUE | Do not stop | Rebound tachycardia and MI if withdrawn |
| Steroids (chronic) | STRESS DOSE | Day of surgery | Adrenal suppression → cardiovascular collapse |
| Drug | Action | Timing |
|---|---|---|
| Metformin | STOP | 24-48h pre-op |
| SGLT-2i | STOP | 3-4 days pre-op |
| Long-acting SU (glibenclamide) | STOP | 48h pre-op |
| Short-acting SU (glipizide) | STOP | Morning of surgery |
| DPP-4 inhibitors | Continue | Until morning of surgery |
| GLP-1 injectable | HOLD | Day of surgery |
| Basal insulin | Give 75-80% of dose | Evening before surgery |
| Bolus insulin | HOLD | Morning of surgery |
10% → Delay elective surgery; infection risk ×3, AKI risk ×2, wound complication ×2
| Drug | Action |
|---|---|
| Prednisolone ≤10 mg/day | Continue + stress dose for major surgery |
| Prednisolone >10 mg/day | Mandatory stress dosing (hydrocortisone 100 mg IV at induction + 25 mg q8h × 24-48h) |
| Methotrexate | Continue (stopping increases flare risk without reducing infection) |
| TNF inhibitors (adalimumab, etanercept) | Withhold 1 half-life before elective surgery; restart when wound healed |
| Rituximab | Withhold up to 6 months pre-elective surgery |
| Hydroxychloroquine | Continue always |
| Leflunomide | Continue minor surgery; rheumatology input for major surgery |
| Patient Profile | Recommendation |
|---|---|
| CFS 1-4, MoCA ≥26, good cardiac reserve | GA with standard ERAS. No restriction. |
| CFS 5-6, MoCA 22-25, RCRI 1-2 | Regional/neuraxial preferred if surgically feasible. If GA: TIVA over volatile agents. Minimize benzodiazepine premedication. BIS monitoring. |
| CFS 5-6, MoCA 18-22, RCRI ≥2 | Regional/neuraxial strongly preferred. If GA unavoidable: TIVA, BIS-guided, dexmedetomidine infusion over propofol bolus for sedation, sugammadex over neostigmine for reversal, avoid anticholinergics. |
| CFS ≥7, MoCA <18, RCRI ≥2 | Neuraxial only if feasible. If GA required: shortest possible duration, lightest depth, ICU post-op mandatory, immediate family delirium briefing. |
| Diastolic dysfunction/HFpEF | Any technique: euvolemia, HR 60-75, MAP 70-90. Slow incremental neuraxial to avoid sympathectomy. |
| Severe AS (AVA <1.0 cm²) | Haemodynamic-stable induction. Arterial line mandatory. Avoid spinal hypotension. |
| CKD eGFR <30 | MAP >70 mmHg intraoperatively non-negotiable. Avoid nephrotoxic NMBs (pancuronium). Use atracurium (Hofmann elimination). |
| COPD moderate-severe | Avoid bronchospasm triggers. Ketamine useful for induction (bronchodilator). LMA preferred over ETT if possible. Epidural excellent for thoracic/abdominal surgery. |
| DM with autonomic neuropathy | Warn of haemodynamic instability at induction. Vasopressor-ready. Phenylephrine infusion preferred (preserves HR unlike other vasopressors). |
| OSA | TIVA preferred. Opioid-minimizing strategy. HDU post-op. CPAP available. |
GERIATRIC PERIOPERATIVE CONSULTATION REPORT
Patient: [Name/Age/Sex] Surgery: [Procedure] Surgeon: [Name]
Date of Surgery: [Date] Urgency: Emergency / Urgent / Elective
─────────────────────────────────────────────────────────────────
RISK PROFILE
CFS: [score/9] | RCRI: [score/6] | MoCA: [score/30]
Albumin: [value] | Hb: [value] | NT-proBNP: [value] | CCI: [score]
Surgical Risk Class: Low / Intermediate / High
OVERALL RISK: ✅ GREEN / ⚠️ YELLOW / 🔴 ORANGE / 🔴🔴 RED
[One sentence summary: "High-frailty (CFS 6) elderly patient with moderate cardiac risk
(RCRI 2) and mild cognitive impairment (MoCA 21) undergoing intermediate-risk surgery.
Estimated 30-day MACE risk 7-12%. Delirium probability 40-50% without prevention protocol."]
─────────────────────────────────────────────────────────────────
ANAESTHESIA RECOMMENDATION
[e.g., "Regional/neuraxial preferred. If GA: TIVA over volatile agents. BIS monitoring.
Avoid benzodiazepine premedication. Sugammadex for reversal. Target MAP >70 mmHg.
Strict euvolemia - diastolic dysfunction present (E/e' 16 on echo)."]
─────────────────────────────────────────────────────────────────
MEDICATION CHANGES (Implemented / Pending)
STOP: [drug, timing]
HOLD: [drug, timing]
ADD: [drug, dose, timing]
STRESS DOSE: [if applicable]
─────────────────────────────────────────────────────────────────
OPTIMIZATION PROTOCOL
[Tier 1/2/3 specific actions with timeline and responsible party]
─────────────────────────────────────────────────────────────────
DELIRIUM PREVENTION
[Yes/No flag + brief protocol - ward nursing instructions]
─────────────────────────────────────────────────────────────────
FAMILY COUNSELLING DOCUMENTED
[Yes - risk explained including delirium probability, discharge destination,
recovery timeline. Family understands and consents.]
─────────────────────────────────────────────────────────────────
FURTHER INVESTIGATIONS REQUIRED (if any)
[e.g., "Echo - not done in last 12 months; RCRI 2 + METs <4 + intermediate surgery"]
─────────────────────────────────────────────────────────────────
Consulting Physician: [Your name/credentials]
Contact: [For follow-up queries]